MindWalk Holdings (HYFT) EBT (QoQ) (2020 - 2026)
MindWalk Holdings (HYFT) EBT (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 81.35% |
| Jan 31, 2026 | -100.67% |
| Oct 31, 2025 | -99.89% |
| Jul 31, 2025 | 17,483,947.26% |
| Apr 30, 2025 | -100.08% |
| Jan 31, 2025 | 749.73% |
| Oct 31, 2024 | -99.93% |
| Jul 31, 2024 | 8,348.53% |
| Apr 30, 2024 | -1,451.92% |
| Jan 31, 2024 | -99.84% |
| Oct 31, 2023 | -58.21% |
| Jul 31, 2023 | 10,364.31% |
| Apr 30, 2023 | -4,847.61% |
| Jan 31, 2023 | -82.50% |
| Oct 31, 2022 | 46,215.42% |
| Jul 31, 2022 | 99.94% |
| Apr 30, 2022 | -474,856.73% |
| Jan 31, 2022 | 31.36% |
| Oct 31, 2021 | -64.50% |
| Jul 31, 2021 | 99.90% |